Miao Lele, Zhang Juan, Xu Wei, Qian Qian, Zhang Guochao, Yuan Quan, Lv Yuetao, Zhang Haiguo, Shen Chaoyan, Wang Wei
Department of Thyroid and Breast Surgery, Jining NO.1 People's Hospital, Jining, China.
Department of Hematology, Jining NO.1 People's Hospital, Jining, China.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2338984. doi: 10.1080/21645515.2024.2338984. Epub 2024 May 2.
CAR-T cell therapy has emerged as a significant approach for the management of hematological malignancies. Over the past few years, the utilization of CAR-T cells in the investigation and treatment of solid tumors has gained momentum, thereby establishing itself as a prominent area of research. This descriptive study involved the retrieval of articles about CAR-T cell therapy for solid tumors from the Web of Science Core Collection (WoSCC) database. Subsequently, bibliometric analysis and knowledge map analysis were conducted on these articles. The field under consideration is currently experiencing a period of swift advancement, as evidenced by the escalating number of publications in this domain each year. The United States holds an indisputable position as the foremost leader in this particular field, with the University of Pennsylvania emerging as the most active institution. The authors with the highest citation frequency and co-citation frequency are Carl H. June and Shannon L. Maude, respectively. The research hotspots in this field mainly focus on five aspects. Additionally, 10 emerging themes were identified. This study undertakes a comprehensive, systematic, and objective analysis and exploration of the field of CAR-T cell treatment for solid tumors, utilizing bibliometric methods. The findings of this study are expected to serve as a valuable reference and enlightenment for future research endeavors in this particular domain.
嵌合抗原受体T细胞(CAR-T)疗法已成为治疗血液系统恶性肿瘤的一种重要方法。在过去几年中,CAR-T细胞在实体瘤研究和治疗中的应用势头渐强,从而成为一个突出的研究领域。这项描述性研究涉及从科学引文索引核心合集(WoSCC)数据库中检索有关CAR-T细胞治疗实体瘤的文章。随后,对这些文章进行了文献计量分析和知识图谱分析。鉴于该领域每年发表的文章数量不断增加,目前正处于快速发展阶段。美国在这一特定领域占据无可争议的领先地位,宾夕法尼亚大学是最活跃的机构。被引频次最高和共被引频次最高的作者分别是卡尔·H·朱恩(Carl H. June)和香农·L·莫德(Shannon L. Maude)。该领域的研究热点主要集中在五个方面。此外,还确定了10个新兴主题。本研究利用文献计量方法,对实体瘤CAR-T细胞治疗领域进行了全面、系统和客观的分析与探索。预计本研究结果将为该特定领域未来的研究工作提供有价值的参考和启示。
Hum Vaccin Immunother. 2024-12-31
Hum Vaccin Immunother. 2024-12-31
Front Immunol. 2022
Hum Vaccin Immunother. 2023-12-15
Hum Vaccin Immunother. 2023-12-15
Hum Vaccin Immunother. 2024-12-31
Biology (Basel). 2025-8-12
Curr Issues Mol Biol. 2025-4-10
Perioper Med (Lond). 2025-3-17
Hum Vaccin Immunother. 2025-12
Naunyn Schmiedebergs Arch Pharmacol. 2024-12
J Transl Med. 2023-9-22
J Hematol Oncol. 2023-9-9
Front Oncol. 2023-7-7
Biochim Biophys Acta Rev Cancer. 2023-7